Word on the Street:The Buy-Side View for 2013

The BIO CEO Investor Conference remains one of the most important events for companies, investors and industry executives to explore partnerships, raise capital, network or simply gain some useful, fresh insight from industry experts. Monday’s opening Plenary Session, Word on the Street–Buy Side View for 2013, was informative and featured some of the industry’s most respected names.

Read more »

BIOTECH 2012: Panel of CEOs — Lather, Rinse, Repeat

Hosted by BioNJ, Pennsylvania Bio and Delaware Bio, their three word mission: “Find. Fund. Facilitate.” was clearly accomplished. Networking is still an integral part of these cerebral gatherings, however programming at this conference provided attendees with candid information, stimulating conversation and a new perspective on the industry.

Read more »

The International BIO Convention Discussed Two Key Fundamentals in Bringing Therapies to Market

BIO (Biotechnology Industry Organization) and OneMedPlace share many of the same goals. Both groups want to see innovative and effective life science therapies come to the marketplace.

Read more »

“Inside the FDA” session at BIO CEO Addressed PDUFA and TREAT Acts

This is one of the largest sources of frustration currently among health care companies and investors.

Read more »

BIO CEO & Investor Conference Has Grown in Size and Offered Insight on Industry Mood

According to BIO’s statistics, “a majority of investors (56%) still think now is a good time to invest.

Read more »

Intellect Neurosciences Files New Patent Applications for Immunotherapy Methods in Treatment of Alzheimer’s Disease

Over the next 40 years, caring for individuals with Alzheimer’s will cost American society $20 trillion –including $15 trillion to Medicare and Medicaid.

Read more »

Will Contrast-Induced Nephropathy Kill You?

Contrast-induced nephropathy (CIN) is a form of acute renal failure precipitated by exposure to these radiocontrast agents. In other words, it is hospital-acquired. The question is: will it kill you?

Read more »